S&P/TSX Composite Index Ends 0.92% Higher at 19837.65 — Data Talk
The S&P/TSX Composite Index is up 180.12 points or 0.92% today to 19837.65
--Largest one-day point and percentage gain since Friday, March 3, 2023
--Up for four consecutive trading days
--Up 377.73 points or 1.94% over the last four trading days
--Largest four-day point and percentage gain since Tuesday, Jan. 17, 2023
--Longest winning streak since Wednesday, Feb. 15, 2023, when the market rose for four straight trading days
--Up six of the past eight trading days
--Off 10.18% from its record close of 22087.22 hit Tuesday, March 29, 2022
--Highest closing value since Thursday, March 9, 2023
--Off 10.18% from its 52-week high of 22085.60 hit Monday, April 4, 2022
--Up 8.96% from its 52-week low of 18206.28 hit Wednesday, Oct. 12, 2022
--Down 10.14% from 52 weeks ago
--Off 4.48% from its 2023 closing high of 20767.38 hit Tuesday, Jan. 31, 2023
--Up 2.37% from its 2023 closing low of 19378.84 hit Wednesday, March 15, 2023
--Month-to-date it is down 1.90%
--Year-to-date it is up 452.73 points or 2.34%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 29, 2023 17:31 ET (21:31 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters